Author: OurCrowd

[EMQ in Yahoo Finance] VBCE and EMQ Team Up to Expand Global Payment Capabilities

Mar 2, 2021 |

Vancouver Bullion & Currency Exchange (VBCE), a leading foreign exchange and payment services provider in Canada, has partnered with global financial settlement network EMQ, to provide near real-time cross-border payments and a broader international reach for businesses and consumers in Canada. By integrating with EMQ’s extensive global network, VBCE’s customers can have instant access to fast, secure and cost-effective cross-border solutions across Asia and Europe, with more markets underway in upcoming months. Read...

Read More

[Rewire in CTech] Israel’s Rewire raises $20 million to expand financial services to migrant workers

Mar 2, 2021 |

Tel Aviv-based fintech company Rewire Ltd., which developed a mobile banking platform for international cash transfers tailored for the needs of expatriate workers, announced on Tuesday that it has completed a $20 million series B funding round. The round was led by OurCrowd and included new key investors Renegade Partners, Glilot Capital Partners, and Jerry Yang, former Yahoo! CEO and director at Alibaba, through AME Cloud Ventures. Read...

Read More

[Zebra in CXOtoday] More Indian Healthcare Firms to Harness the Power of Artificial Intelligence

Mar 2, 2021 |

Much of the world’s attention is now focused on one of the largest industries in the world – healthcare. This is also evident from the India Budget FY 22 where the sector has received a 137% boost in allocation. A recent report observes that even though India’s healthcare firms were relatively slow to start, many of them are now looking at harnessing the power of Artificial Intelligence (AI) since the time of coronavirus and believe its impact will be even greater post the pandemic. Read...

Read More

[Memic in PR Newswire] Memic Receives FDA De Novo Marketing Authorization for First-Ever Surgical Robotic System with Humanoid-shaped Robotic Arms

Mar 1, 2021 |

TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 1, 2021 /PRNewswire/ — Memic, a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization of its Hominis® robot-assisted surgical platform for use in single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures including benign hysterectomy. Read more...

Read More